FDA officials: Payers should be more involved in evidence generation
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesClinical TrialsMedical DevicesPharmaceuticalsReimbursementUnited StatesRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesClinical TrialsMedical DevicesPharmaceuticalsReimbursementUnited States